Outcomes of Antipsychotic Medication Used in the Emergency Department
NCT02504450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93
Last updated 2024-10-04
Summary
To review records of patients treated with antipsychotics (including Adasuve, Geodon, Haldol) in order to evaluate outcomes.
Conditions
- Agitation,Psychomotor
Interventions
- DRUG
-
Adasuve
Inhaled medication to treat acute agitation in the emergency department
- DRUG
-
Alternative medications
Medication given to treat acute agitation in the emergency department
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Erik Kulstad, MD · Advocate Healthcare
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
More Related Trials
-
Pattern of Acute Antipsychotic Drug- Toxicity in Children
NCT06125275 ·Status: NOT_YET_RECRUITING
-
Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial
NCT01892995 ·Status: UNKNOWN ·Phase: NA
-
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
NCT06395428 ·Status: RECRUITING ·Phase: PHASE4
-
Drug Interactions With Risk of QT-prolongation in a General Hospital
NCT02043912 ·Status: COMPLETED
-
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
NCT03095066 ·Status: COMPLETED ·Phase: PHASE2
-
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
NCT02643355 ·Status: COMPLETED ·Phase: NA
-
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
NCT05974527 ·Status: WITHDRAWN ·Phase: PHASE4
-
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567 ·Status: TERMINATED ·Phase: PHASE3
-
Ketamine for Low Mood States in the ER
NCT01209845 ·Status: COMPLETED ·Phase: PHASE1
-
Characterization of the Prosocial and Prosexual Effects of GHB
NCT02342366 ·Status: COMPLETED ·Phase: NA
-
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
NCT03110900 ·Status: TERMINATED ·Phase: PHASE4
-
IV Haloperidol for the Treatment of Headache in the ED
NCT02747511 ·Status: COMPLETED ·Phase: PHASE4
-
PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel
NCT03199950 ·Status: UNKNOWN ·Phase: PHASE4
-
Rapid Agitation Control With Ketamine in the Emergency Department
NCT03375671 ·Status: COMPLETED ·Phase: PHASE2
-
ESM Pilot: Mobile Phones and Psychology
NCT03221985 ·Status: COMPLETED ·Phase: NA
-
pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for Delirium
NCT01785290 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678 ·Status: COMPLETED ·Phase: PHASE1
-
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
NCT03481192 ·Status: UNKNOWN ·Phase: NA
-
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
NCT04178993 ·Status: COMPLETED ·Phase: PHASE1
-
The Human Stress Response in a Simulated ED Setting
NCT04317482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
NCT00184184 ·Status: COMPLETED
-
Evaluating Ketamine and Psychological Sequelae
NCT04053400 ·Status: COMPLETED
-
Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder
NCT02055638 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Identification of Psychoactive Substance Users in Young Adults (16 to 25 Years Old) Visiting the Emergency Department
NCT04173546 ·Status: COMPLETED